BILL · 2013–14 SESSION

SB 6073: Eosinophilic GI disorders

Concerning the treatment of eosinophilic gastrointestinal associated disorders.

Summary

Health benefit plans issued or renewed after December 31, 2015, must offer benefits or coverage for medically necessary elemental formula, regardless of delivery method, when a licensed health care provider with prescriptive authority: (1) diagnoses a patient with EGIDs; and (2) orders and supervises the use of the elemental formula.

From the Senate Bill Report (Orig.) (SB 6073), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to the treatment of eosinophilic gastrointestinal associated disorders;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

SB 6073 (2025–26) Wildland firefighters/LEOFF · Did not pass · died in committee
SB 6073 (2023–24) AI use in court filings · Did not pass · died in committee
SB 6073 (2019–20) Menstrual products/schools · Did not pass · passed Senate, stalled in House
SB 6073 (2017–18) Hardwood processors levy · Enacted · Chapter 71, Laws of 2018
SB 6073 (2015–16) Trans funding, approps T.O. · Did not pass · died in committee
SB 6073 (2011–12) SR 16 project/sales & use tx · Enacted · Chapter 77, Laws of 2012
SB 6073 (2009–10) Profoundly divergent studnts · Did not pass · died in committee
SB 6073 (2007–08) Manufactured/mobile home · Did not pass · died in committee